Page 7 - Ioscience News Today

Initiated collaboration with Graviton Bioscience to develop selective ROCK2 inhibitors for rare neurological diseasesLong-term data supporting soticlestat safety, tolerability and seizure-reduction... | May 5, 2023

Alligator Bioscience has been off to a hot start in 2023. First came the positive interim results from the phase II study in pancreatic cancer. Then, the first patient was dosed in a phase I study for... | May 4, 2023

WOBURN, Mass., May 03, 2023 -- Yield10 Bioscience, Inc. , an agricultural bioscience company, today announced that it has agreed to sell $3.0 million of its shares of common stock in a registered... | May 3, 2023

WOBURN, Mass., May 01, 2023 -- Yield10 Bioscience, Inc. , an agricultural bioscience company, today announced that it has signed a non-binding Letter of Intent with Marathon Petroleum Corp.... | May 1, 2023

LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202... | May 1, 2023

Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million

Clinical study will evaluate safety and tolerability of Lexaria's patented DehydraTECH-CBD as a potential treatment for hypertensionCalifornia-based InClin to provide CRO services to manage and expedite

Connecticut provides an environment that is conducive to growth and expansion across a diverse array of industries.

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics...

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas... | April 20, 2023